Advertisement
Advertisement
U.S. markets open in 2 hours 17 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Finch Therapeutics Group, Inc. (FNCH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7500-0.1200 (-6.42%)
At close: 04:00PM EDT
1.8400 +0.09 (+5.14%)
After hours: 05:12PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
12,864
18,532
7,719
10,154
Cost of Revenue
-
-
0
314
Gross Profit
-
-
7,719
9,840
Operating Expense
88,166
78,517
47,155
30,982
Operating Income
-75,302
-59,985
-39,436
-21,142
Net Non Operating Interest Income Expense
-36
22
106
488
Other Income Expense
-939
1,803
-11
-100
Pretax Income
-76,277
-58,160
-39,341
-20,754
Tax Provision
0
0
0
0
Net Income Common Stockholders
-76,277
-58,160
-39,341
-20,754
Diluted NI Available to Com Stockholders
-76,277
-58,160
-39,341
-20,754
Basic EPS
-
-1.48
-1.13
-0.60
Diluted EPS
-
-1.48
-1.13
-0.60
Basic Average Shares
-
39,202
34,692
34,692
Diluted Average Shares
-
39,202
34,692
34,692
Total Operating Income as Reported
-76,205
-59,985
-39,436
-21,142
Total Expenses
88,166
78,517
47,155
31,296
Net Income from Continuing & Discontinued Operation
-76,277
-58,160
-39,341
-20,754
Normalized Income
-75,368
-60,015
-39,328
-20,614
Interest Income
-
22
106
488
Net Interest Income
-36
22
106
488
EBIT
-75,302
-59,985
-39,436
-21,142
EBITDA
-71,292
-
-
-
Reconciled Cost of Revenue
-
-
0
314
Reconciled Depreciation
4,010
2,301
790
482
Net Income from Continuing Operation Net Minority Interest
-76,277
-58,160
-39,341
-20,754
Total Unusual Items Excluding Goodwill
-909
1,855
-13
-140
Total Unusual Items
-909
1,855
-13
-140
Normalized EBITDA
-70,383
-59,539
-38,633
-20,520
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement